{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:22:10Z","timestamp":1782249730388,"version":"3.54.5"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13555-026-01712-2","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:36:28Z","timestamp":1773840988000},"page":"1869-1887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Narrative Review of Local Therapies in Hidradenitis Suppurativa: Treatment Landscape and Current Issues"],"prefix":"10.1007","volume":"16","author":[{"given":"Elisa","family":"Molinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Febi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8052-9324","authenticated-orcid":false,"given":"Edoardo","family":"De Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Dragonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Richiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Candelora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Gambini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Belleggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guendalina","family":"Lucarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"10476","key":"1712_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0140-6736(24)02475-9","volume":"405","author":"R Sabat","year":"2025","unstructured":"Sabat R, Alavi A, Wolk K, Wortsman X, McGrath B, Garg A, et al. Hidradenitis suppurativa. Lancet. 2025;405(10476):420\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(24)02475-9. (PubMed PMID: 39862870.).","journal-title":"Lancet"},{"key":"1712_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/20406223211055920","volume":"12","author":"V Amat-Samaranch","year":"2021","unstructured":"Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2021;12:20406223211055920.","journal-title":"Ther Adv Chronic Dis"},{"key":"1712_CR3","doi-asserted-by":"crossref","unstructured":"Binchi L, Caposiena Caro R D, Ganzetti G, Molinelli E, Dini V, Oranges T, et al. Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. Clinical and experimental dermatology [Internet]. 2019 Jul [cited 2025 Jul 28];44(5). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30593710\/","DOI":"10.1111\/ced.13861"},{"issue":"9","key":"1712_CR4","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.3390\/ijms24098428","volume":"24","author":"E Molinelli","year":"2023","unstructured":"Molinelli E, Gioacchini H, Sapigni C, Diotallevi F, Brisigotti V, Rizzetto G, et al. New insight into the molecular pathomechanism and immunomodulatory treatments of hidradenitis suppurativa. Int J Mol Sci. 2023;24(9):8428.","journal-title":"Int J Mol Sci"},{"key":"1712_CR5","doi-asserted-by":"crossref","unstructured":"Caposiena Caro RD, Molinelli E, Brisigotti V, Offidani A, Bianchi L. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation. Clin Exp Dermatol. 2021 Jan;46(1):96\u2013102.","DOI":"10.1111\/ced.14388"},{"key":"1712_CR6","doi-asserted-by":"crossref","unstructured":"Diotallevi F, Campanati A, Martina E, Radi G, Paolinelli M, Marani A, et al. The role of nutrition in immune-mediated, inflammatory skin disease: a narrative review. Nutrients [Internet]. 2022 Jan 29 [cited 2025 Jul 28];14(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35276950\/","DOI":"10.3390\/nu14030591"},{"issue":"11","key":"1712_CR7","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ced\/llad229","volume":"48","author":"E Molinelli","year":"2023","unstructured":"Molinelli E, Gambini D, Maurizi A, De Simoni E, Sapigni C, Belleggia S, et al. Bimekizumab in hidradenitis suppurativa: a valid and effective emerging treatment. Clin Exp Dermatol. 2023;48(11):1272\u20134.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"1712_CR8","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/antibiotics12060978","volume":"12","author":"E Molinelli","year":"2023","unstructured":"Molinelli E, De Simoni E, Candelora M, Sapigni C, Brisigotti V, Rizzetto G, et al. Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues. Antibiotics (Basel). 2023;12(6):978.","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"1712_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/bjd.19337","volume":"183","author":"E Molinelli","year":"2020","unstructured":"Molinelli E, Brisigotti V, Simonetti O, Campanati A, Sapigni C, D\u2019Agostino GM, et al. Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance. Br J Dermatol. 2020;183(6):1117\u20139.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1712_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s13555-024-01169-1","volume":"14","author":"E Molinelli","year":"2024","unstructured":"Molinelli E, Gioacchini H, Marani A, Rizzetto G, Gambini D, De Simoni E, et al. Topical and systemic retinoids in the management of hidradenitis suppurativa: a comprehensive literature review. Dermatol Ther (Heidelb). 2024;14(5):1079\u201391.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"1712_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jaad.2021.10.060","volume":"87","author":"E Molinelli","year":"2022","unstructured":"Molinelli E, Sapigni C, Simonetti O, Brisigotti V, Giuliodori K, Offidani A. Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: a controlled prospective clinical study. J Am Acad Dermatol. 2022;87(3):674\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1712_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.det.2024.02.001","volume":"42","author":"AM Wride","year":"2024","unstructured":"Wride AM, Chen GF, Spaulding SL, Tkachenko E, Cohen JM. Biologics for psoriasis. Dermatol Clin. 2024;42(3):339\u201355.","journal-title":"Dermatol Clin"},{"issue":"1","key":"1712_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1574886310666151014115532","volume":"11","author":"A Campanati","year":"2016","unstructured":"Campanati A, Ganzetti G, Giuliodori K, Molinelli E, Offidani A. Biologic therapy in psoriasis: safety profile. Curr Drug Saf. 2016;11(1):4\u201311.","journal-title":"Curr Drug Saf"},{"issue":"1","key":"1712_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1574886310666151014115127","volume":"11","author":"E Molinelli","year":"2016","unstructured":"Molinelli E, Campanati A, Ganzetti G, Offidani A. Biologic therapy in immune mediated inflammatory disease: basic science and clinical concepts. Curr Drug Saf. 2016;11(1):35\u201343.","journal-title":"Curr Drug Saf"},{"issue":"19","key":"1712_CR15","doi-asserted-by":"publisher","first-page":"11128","DOI":"10.3390\/ijms231911128","volume":"23","author":"F Diotallevi","year":"2022","unstructured":"Diotallevi F, Simonetti O, Rizzetto G, Molinelli E, Radi G, Offidani A. Biological treatments for pediatric psoriasis: state of the art and future perspectives. Int J Mol Sci. 2022;23(19):11128.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1712_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/jdv.20472","volume":"39","author":"CC Zouboulis","year":"2025","unstructured":"Zouboulis CC, Bechara FG, Benhadou F, Bettoli V, Bukvi\u0107 Mokos Z, Del Marmol V, et al. European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: treatment. J Eur Acad Dermatol Venereol. 2025;39(5):899\u2013941.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1712_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000503605","volume":"237","author":"AJ Hendricks","year":"2021","unstructured":"Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A comparison of international management guidelines for hidradenitis suppurativa. Dermatology. 2021;237(1):81\u201396.","journal-title":"Dermatology"},{"issue":"4","key":"1712_CR18","first-page":"381","volume":"10","author":"ES Schweiger","year":"2011","unstructured":"Schweiger ES, Riddle CC, Aires DJ. Treatment of hidradenitis suppurativa by photodynamic therapy with aminolevulinic acid: preliminary results. J Drugs Dermatol. 2011;10(4):381\u20136.","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"1712_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/antibiotics10111377","volume":"10","author":"O Simonetti","year":"2021","unstructured":"Simonetti O, Rizzetto G, Radi G, Molinelli E, Cirioni O, Giacometti A, et al. New perspectives on old and new therapies of staphylococcal skin infections: the role of biofilm targeting in wound healing. Antibiotics (Basel). 2021;10(11):1377.","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"1712_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3934\/microbiol.2022011","volume":"8","author":"O Simonetti","year":"2022","unstructured":"Simonetti O, Marasca S, Candelora M, Rizzetto G, Radi G, Molinelli E, et al. Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management. AIMS Microbiol. 2022;8(2):125\u201337.","journal-title":"AIMS Microbiol"},{"key":"1712_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/2040622319830646","volume":"10","author":"JW Frew","year":"2019","unstructured":"Frew JW, Hawkes JE, Krueger JG. Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Ther Adv Chronic Dis. 2019;10:2040622319830646.","journal-title":"Ther Adv Chronic Dis"},{"issue":"4","key":"1712_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1159\/000530758","volume":"239","author":"P Aarts","year":"2023","unstructured":"Aarts P, Reeves JL, Ardon CB, Van Der Zee HH, Prens EP. Clindamycin-Benzoyl Peroxide gel compared with Clindamycin lotion for Hidradenitis Suppurativa: a randomized controlled assessor-blinded intra-patient pilot study. Dermatology. 2023;239(4):670\u20134.","journal-title":"Dermatology"},{"key":"1712_CR23","doi-asserted-by":"crossref","unstructured":"Lio PA, Kaye ET. Topical antibacterial agents. Infect Dis Clin North Am. 2009; 23(4):945\u201363, ix.","DOI":"10.1016\/j.idc.2009.06.006"},{"issue":"1","key":"1712_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/CMR.12.1.147","volume":"12","author":"G McDonnell","year":"1999","unstructured":"McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147\u201379.","journal-title":"Clin Microbiol Rev"},{"key":"1712_CR25","doi-asserted-by":"crossref","unstructured":"O\u2019toole EA, Goel M, Woodley DT. Hydrogen peroxide inhibits human keratinocyte migration. Dermatologic Surgery. 1996;22(6):525\u20139.","DOI":"10.1111\/j.1524-4725.1996.tb00368.x"},{"issue":"2","key":"1712_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jse.2019.09.038","volume":"29","author":"JD Stull","year":"2020","unstructured":"Stull JD, Nicholson TA, Davis DE, Namdari S. Addition of 3% hydrogen peroxide to standard skin preparation reduces Cutibacterium acnes-positive culture rate in shoulder surgery: a prospective randomized controlled trial. J Shoulder Elbow Surg. 2020;29(2):212\u20136.","journal-title":"J Shoulder Elbow Surg"},{"issue":"1","key":"1712_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13063-022-06042-0","volume":"23","author":"S Primhak","year":"2022","unstructured":"Primhak S, Gataua A, Purvis D, Thompson JMD, Walker C, Best E, et al. Treatment of Impetigo with Antiseptics-Replacing Antibiotics (TIARA) trial: a single blind randomised controlled trial in school health clinics within socioeconomically disadvantaged communities in New Zealand. Trials. 2022;23(1):108.","journal-title":"Trials"},{"key":"1712_CR28","doi-asserted-by":"crossref","unstructured":"Gocke DJ, Ponticas S, Pollack W. In vitro studies of the killing of clinical isolates by povidone-iodine solutions. J Hosp Infect. 1985;6 Suppl A:59\u201366.","DOI":"10.1016\/S0195-6701(85)80047-5"},{"issue":"2","key":"1712_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.14463","volume":"21","author":"D Bai","year":"2023","unstructured":"Bai D, Zhou F, Wu L. Comparing the efficacy of chlorhexidine and povidone\u2013iodine in preventing surgical site infections: a systematic review and meta-analysis. Int Wound J. 2023;21(2):e14463.","journal-title":"Int Wound J"},{"issue":"2","key":"1712_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0195-6701(93)90014-Q","volume":"23","author":"G Nicoletti","year":"1993","unstructured":"Nicoletti G, Boghossian V, Gurevitch F, Borland R, Morgenroth P. The antimicrobial activity in vitro of chlorhexidine, a mixture of isothiazolinones (\u2018Kathon\u2019 CG) and cetyl trimethyl ammonium bromide (CTAB). J Hosp Infect. 1993;23(2):87\u2013111.","journal-title":"J Hosp Infect"},{"issue":"3","key":"1712_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1086\/646137","volume":"11","author":"EL Larson","year":"1990","unstructured":"Larson EL, Butz AM, Gullette DL, Laughon BA. Alcohol for surgical scrubbing? Infect Control Hosp Epidemiol. 1990;11(3):139\u201343.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"1712_CR32","first-page":"677","volume":"152","author":"AF Kaul","year":"1981","unstructured":"Kaul AF, Jewett JF. Agents and techniques for disinfection of the skin. Surg Gynecol Obstet. 1981;152(5):677\u201385.","journal-title":"Surg Gynecol Obstet"},{"issue":"5","key":"1712_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00006454-199405000-00024","volume":"13","author":"L Mermel","year":"1994","unstructured":"Mermel L. Choice of disinfectants in obtaining blood cultures. Pediatr Infect Dis J. 1994;13(5):425\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"1712_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40265-015-0516-5","volume":"76","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Prens EP. An update on medical treatment options for hidradenitis suppurativa. Drugs. 2016;76(2):215\u201329.","journal-title":"Drugs"},{"issue":"9","key":"1712_CR35","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1086\/519929","volume":"28","author":"C Wendt","year":"2007","unstructured":"Wendt C, Schinke S, W\u00fcrttemberger M, Oberdorfer K, Bock-Hensley O, von Baum H. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol. 2007;28(9):1036\u201343.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1712_CR36","doi-asserted-by":"crossref","unstructured":"Sandri AM, Dalarosa MG, Ruschel de Alcantara L, da Silva Elias L, Zavascki AP. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol. 2006;27(2):185\u20137.","DOI":"10.1086\/500625"},{"issue":"5","key":"1712_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.NAJ.0000516268.32086.24","volume":"117","author":"DS Aschenbrenner","year":"2017","unstructured":"Aschenbrenner DS. Rare allergic reaction to topical chlorhexidine gluconate. Am J Nurs. 2017;117(5):20. https:\/\/doi.org\/10.1097\/01.NAJ.0000516268.32086.24.","journal-title":"Am J Nurs"},{"key":"1712_CR38","doi-asserted-by":"publisher","unstructured":"Anderson BJ, Tanenbaum ZG, Michael A, Owen SR. Cutaneous hypersensitivity to chlorhexidine following facial fat grafting: a delayed intradermal response. J Surg Case Rep. 2024;2024(7):rjae103. https:\/\/doi.org\/10.1093\/jscr\/rjae103. PMID: 38974088; PMCID: PMC11226778.","DOI":"10.1093\/jscr\/rjae103"},{"key":"1712_CR39","unstructured":"Thune P. To pasienter med klorheksidinallergi--anafylaktiske reaksjoner og eksem [Two patients with chlorhexidine allergy--anaphylactic reactions and eczema]. Tidsskr Nor Laegeforen. 1998;118(21):3295\u20136. Norwegian. PMID: 9772819."},{"issue":"1","key":"1712_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0310057X20973046","volume":"49","author":"AL Carle","year":"2021","unstructured":"Carle AL, Martyr JW, Boddu K, Archer SG. Allergic contact dermatitis to a dye or alcohol in a chlorhexidine-based skin preparation: a case report. Anaesth Intensive Care. 2021;49(1):70\u20133. https:\/\/doi.org\/10.1177\/0310057X20973046. (Epub 2021 Jan 27. PMID: 33504168.).","journal-title":"Anaesth Intensive Care"},{"issue":"11","key":"1712_CR41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bdj.2012.1086","volume":"213","author":"MN Pemberton","year":"2012","unstructured":"Pemberton MN, Gibson J. Chlorhexidine and hypersensitivity reactions in dentistry. Br Dent J. 2012;213(11):547\u201350. https:\/\/doi.org\/10.1038\/sj.bdj.2012.1086. (PMID: 23222325.).","journal-title":"Br Dent J"},{"key":"1712_CR42","doi-asserted-by":"publisher","DOI":"10.5620\/eht.e2017004","volume":"32","author":"KS Yoon","year":"2017","unstructured":"Yoon KS, Youn N, Gu H, Kwack SJ. Estrogenic activity of zinc pyrithione: an in vivo and in vitro study. Environ Health Toxicol. 2017;32:e2017004.","journal-title":"Environ Health Toxicol"},{"issue":"1","key":"1712_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajic.2004.07.012","volume":"33","author":"E Guthery","year":"2005","unstructured":"Guthery E, Seal LA, Anderson EL. Zinc pyrithione in alcohol-based products for skin antisepsis: persistence of antimicrobial effects. Am J Infect Control. 2005;33(1):15\u201322.","journal-title":"Am J Infect Control"},{"issue":"5","key":"1712_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.07.026","volume":"73","author":"MJ Danesh","year":"2015","unstructured":"Danesh MJ, Kimball AB. Pyrithione zinc as a general management strategy for hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5):e175.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1712_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jdermsci.2016.08.010","volume":"84","author":"S Hessam","year":"2016","unstructured":"Hessam S, Sand M, Meier NM, Gambichler T, Scholl L, Bechara FG. Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa. J Dermatol Sci. 2016;84(2):197\u2013202.","journal-title":"J Dermatol Sci"},{"issue":"3","key":"1712_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","volume":"17","author":"W Gulliver","year":"2016","unstructured":"Gulliver W, Zouboulis CC, Prens E, Jemec GBE, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord. 2016;17(3):343\u201351.","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"1712_CR47","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00146-18","volume":"62","author":"MM Maiden","year":"2018","unstructured":"Maiden MM, Hunt AMA, Zachos MP, Gibson JA, Hurwitz ME, Mulks MH, et al. Triclosan is an aminoglycoside adjuvant for eradication of Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2018;62(6):e00146-18. https:\/\/doi.org\/10.1128\/AAC.00146-18. (PMID: 29661867; PMCID: PMC5971565.).","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"1712_CR48","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1172\/JCI70895","volume":"123","author":"TH Leung","year":"2013","unstructured":"Leung TH, Zhang LF, Wang J, Ning S, Knox SJ, Kim SK. Topical hypochlorite ameliorates NF-\u03baB-mediated skin diseases in mice. J Clin Invest. 2013;123(12):5361\u201370.","journal-title":"J Clin Invest"},{"issue":"10","key":"1712_CR49","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/INF.0b013e318175d871","volume":"27","author":"RG Fisher","year":"2008","unstructured":"Fisher RG, Chain RL, Hair PS, Cunnion KM. Hypochlorite killing of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2008;27(10):934\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"1712_CR50","unstructured":"296 Bleach baths promote early induction of inflammatory pathway genes with no effect on skin bacterial dysbiosis in AD subjects | Semantic Scholar [Internet]. [cited 2024 Apr 8]. Available from: https:\/\/www.semanticscholar.org\/paper\/296-Bleach-baths-promote-early-induction-of-pathway-Knowlden-Yoshida\/b186951fd5360857153b71c2b54f74e4714c7e71"},{"issue":"3","key":"1712_CR51","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1073\/pnas.1011033108","volume":"108","author":"AK Epstein","year":"2011","unstructured":"Epstein AK, Pokroy B, Seminara A, Aizenberg J. Bacterial biofilm shows persistent resistance to liquid wetting and gas penetration. Proc Natl Acad Sci U S A. 2011;108(3):995\u20131000.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1712_CR52","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.1992.tb00104.x","volume":"126","author":"KS Harkaway","year":"1992","unstructured":"Harkaway KS, McGinley KJ, Foglia AN, Lee WL, Fried F, Shalita AR, et al. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol. 1992;126(6):586\u201390.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1712_CR53","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","volume":"39","author":"GB Jemec","year":"1998","unstructured":"Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39(6):971\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"1712_CR54","doi-asserted-by":"crossref","unstructured":"Pona A, Quan EY, Cline A, Feldman SR. Review of the use of gentian violet in dermatology practice. Dermatol Online J. 2020 May 15;26(5):13030\/qt79g6z0cf.","DOI":"10.5070\/D3265048772"},{"issue":"3","key":"1712_CR55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0195-6701(95)90070-5","volume":"31","author":"M Saji","year":"1995","unstructured":"Saji M, Taguchi S, Uchiyama K, Osono E, Hayama N, Ohkuni H. Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect. 1995;31(3):225\u20138.","journal-title":"J Hosp Infect"},{"issue":"5","key":"1712_CR56","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/089686089701700515","volume":"17","author":"M Moys\u00e9s-Neto","year":"1997","unstructured":"Moys\u00e9s-Neto M, Cherubini A, Batista ME, Raspanti EO, Vieira-Neto OM, Nakagawa B, et al. Foreign body granuloma at the exit site in patients on CAPD: use of 1% gentian violet as topical treatment. Perit Dial Int. 1997;17(5):509\u201311.","journal-title":"Perit Dial Int"},{"issue":"4","key":"1712_CR57","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/WON.0000000000000343","volume":"44","author":"M Famorca","year":"2017","unstructured":"Famorca M, Beauchaine D, Angulo N. Management of a complex peristomal calciphylaxis: a case study. J Wound Ostomy Continence Nurs. 2017;44(4):380\u20133.","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"5","key":"1712_CR58","first-page":"26","volume":"50","author":"P Conwell","year":"2004","unstructured":"Conwell P, Mikulski L, Moran D, Tramontozzi M. Pyoderma gangrenosum treatment: a steroid-free option. Ostomy Wound Manage. 2004;50(5):26\u20138.","journal-title":"Ostomy Wound Manage"},{"issue":"1","key":"1712_CR59","first-page":"11","volume":"38","author":"CW Thompson","year":"1946","unstructured":"Thompson CW. Topical application of penicillin\u202f: solution, gentian-violet and heat in the treatment of extensive 1st and 2nd degree burns in children. J Natl Med Assoc. 1946;38(1):11\u20134.","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"1712_CR60","first-page":"248","volume":"111","author":"KN Choudhary","year":"2013","unstructured":"Choudhary KN, Soni PP, Sao DK, Murthy R, Deshkar AM, Nanda BR. Role of gentian violet paint in burn wound management: a prospective randomised control trial. J Indian Med Assoc. 2013;111(4):248\u201350.","journal-title":"J Indian Med Assoc"},{"issue":"6","key":"1712_CR61","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/iwj.12753","volume":"14","author":"KY Woo","year":"2017","unstructured":"Woo KY, Heil J. A prospective evaluation of methylene blue and gentian violet dressing for management of chronic wounds with local infection. Int Wound J. 2017;14(6):1029\u201335.","journal-title":"Int Wound J"},{"issue":"3, SUPPL. 1","key":"1712_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.ASW.0000443270.71030.71","volume":"27","author":"PM Coutts","year":"2014","unstructured":"Coutts PM, Ryan J, Sibbald RG. Case series of lower-extremity chronic wounds managed with an antibacterial foam dressing bound with gentian violet and methylene blue. Adv Skin Wound Care. 2014;27(3, SUPPL. 1):9.","journal-title":"Adv Skin Wound Care"},{"issue":"4","key":"1712_CR63","first-page":"107","volume":"29","author":"EJ Lullove","year":"2017","unstructured":"Lullove EJ. Use of ovine-based collagen extracellular matrix and gentian violet\/methylene blue antibacterial foam dressings to help improve clinical outcomes in lower extremity wounds: a retrospective cohort study. Wounds. 2017;29(4):107\u201314.","journal-title":"Wounds"},{"issue":"2\u20133","key":"1712_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/03602539009041083","volume":"22","author":"R Docampo","year":"1990","unstructured":"Docampo R, Moreno SN. The metabolism and mode of action of gentian violet. Drug Metab Rev. 1990;22(2\u20133):161\u201378.","journal-title":"Drug Metab Rev"},{"issue":"1","key":"1712_CR65","first-page":"45","volume":"72","author":"MJ Nyst","year":"1992","unstructured":"Nyst MJ, Perriens JH, Kimputu L, Lumbila M, Nelson AM, Piot P. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. Ann Soc Belg Med Trop. 1992;72(1):45\u201352.","journal-title":"Ann Soc Belg Med Trop"},{"issue":"2\u20133","key":"1712_CR66","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.phymed.2008.07.015","volume":"16","author":"SC Wright","year":"2009","unstructured":"Wright SC, Maree JE, Sibanyoni M. Treatment of oral thrush in HIV\/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet. Phytomedicine. 2009;16(2\u20133):118\u201324.","journal-title":"Phytomedicine"},{"issue":"11","key":"1712_CR67","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1365-4632.2010.04557.x","volume":"49","author":"SS Venugopal","year":"2010","unstructured":"Venugopal SS, Intong LRA, Cohn HI, Mather-Hillon J, Murrell DF. Responsiveness of nonHerlitz junctional epidermolysis bullosa to topical gentian violet. Int J Dermatol. 2010;49(11):1282\u20135.","journal-title":"Int J Dermatol"},{"issue":"5585","key":"1712_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bmj.1.5585.157","volume":"1","author":"RW John","year":"1968","unstructured":"John RW. Necrosis of oral mucosa after local application of crystal violet. Br Med J. 1968;1(5585):157\u20138.","journal-title":"Br Med J"},{"issue":"1","key":"1712_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2340\/00015555525560","volume":"52","author":"A Bj\u00f6rnberg","year":"1972","unstructured":"Bj\u00f6rnberg A, Mobacken H. Necrotic skin reactions caused by 1 per cent gentian violet and brilliant green. Acta Derm Venereol. 1972;52(1):55\u201360.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"1712_CR70","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaad.2009.03.029","volume":"61","author":"JL Arbiser","year":"2009","unstructured":"Arbiser JL. Gentian violet is safe. J Am Acad Dermatol. 2009;61(2):359.","journal-title":"J Am Acad Dermatol"},{"key":"1712_CR71","unstructured":"Topical 15% resorcinol is associated with high treatment satisfaction in patients with mild to moderate hidradenitis suppurativa - PubMed [Internet]. [cited 2024 Nov 25]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33887735\/"},{"key":"1712_CR72","unstructured":"Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders - PubMed [Internet]. [cited 2024 Nov 28]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/1712709\/"},{"issue":"1","key":"1712_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2230.2009.03377.x","volume":"35","author":"J Boer","year":"2010","unstructured":"Boer J, Jemec GBE. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol. 2010;35(1):36\u201340.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"1712_CR74","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jaad.2017.07.008","volume":"77","author":"JC Pascual","year":"2017","unstructured":"Pascual JC, Encabo B, Ruiz de Apodaca RF, Romero D, Selva J, Jemec GB. Topical 15% resorcinol for hidradenitis suppurativa: an uncontrolled prospective trial with clinical and ultrasonographic follow-up. J Am Acad Dermatol. 2017;77(6):1175\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1712_CR75","unstructured":"Boer J, Bos WH. Hidradenitis suppurativa (acne inversa): behandeling met deroofing en resorcine. 2004;14."},{"issue":"11","key":"1712_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15837","volume":"35","author":"M Manfredini","year":"2022","unstructured":"Manfredini M, Alma A, Pongetti L, Sticchi A, Baschieri E, Farnetani F, et al. Topical finasteride: a potential therapeutic option for hidradenitis suppurativa. Dermatol Ther. 2022;35(11):e15837.","journal-title":"Dermatol Ther"},{"key":"1712_CR77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jdcr.2023.04.002","volume":"36","author":"KN Cunningham","year":"2023","unstructured":"Cunningham KN, Moody K, Alorainy M, Rosmarin D. Use of topical clascoterone for the treatment of hidradenitis suppurativa. JAAD Case Rep. 2023;36:38\u20139.","journal-title":"JAAD Case Rep"},{"issue":"2 Suppl 1","key":"1712_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1590\/abd1806-4841.20198607","volume":"94","author":"RF Magalh\u00e3es","year":"2019","unstructured":"Magalh\u00e3es RF, Rivitti-Machado MC, Duarte GV, Souto R, Nunes DH, Chaves M, et al. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology. An Bras Dermatol. 2019;94(2 Suppl 1):7\u201319.","journal-title":"An Bras Dermatol"},{"issue":"1","key":"1712_CR79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91\u2013101.","journal-title":"J Am Acad Dermatol"},{"issue":"2017","key":"1712_CR80","volume":"20","author":"VK Shanmugam","year":"2017","unstructured":"Shanmugam VK, Zaman NM, McNish S, Hant FN. Review of current immunologic therapies for hidradenitis suppurativa. Int J Rheumatol. 2017;20(2017):e8018192.","journal-title":"Int J Rheumatol"},{"issue":"6","key":"1712_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13901","volume":"33","author":"L Fania","year":"2020","unstructured":"Fania L, Clemente A, Sampogna F, Mazzanti C, Pallotta S, Panebianco A, et al. Intralesional ultrasound-guided combined treatment with triamcinolone plus lincomycin in hidradenitis suppurativa: a pilot study. Dermatol Ther. 2020;33(6):e13901.","journal-title":"Dermatol Ther"},{"issue":"306","key":"1712_CR82","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tox.2013.02.006","volume":"5","author":"A Wheeler","year":"2013","unstructured":"Wheeler A, Smith HS. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Toxicology. 2013;5(306):124\u201346.","journal-title":"Toxicology"},{"issue":"12","key":"1712_CR83","first-page":"14115","volume":"13","author":"H Qu","year":"2021","unstructured":"Qu H, Gao L. Botulinum toxin type A for the management of hidradenitis suppurativa. Am J Transl Res. 2021;13(12):14115\u201320.","journal-title":"Am J Transl Res"},{"issue":"6","key":"1712_CR84","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2340\/00015555-1841","volume":"94","author":"\u0141 Matusiak","year":"2014","unstructured":"Matusiak \u0141, Bieniek A, Szepietowski JC. Bacteriology of hidradenitis suppurativa - which antibiotics are the treatment of choice? Acta Derm Venereol. 2014;94(6):699\u2013702.","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"1712_CR85","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00403-013-1380-3","volume":"305","author":"A Campanati","year":"2013","unstructured":"Campanati A, Giuliodori K, Giuliano A, Martina E, Ganzetti G, Marconi B, et al. Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. Arch Dermatol Res. 2013;305(8):691\u20137.","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"1712_CR86","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40257-020-00537-9","volume":"21","author":"\u00d8 Grimstad","year":"2020","unstructured":"Grimstad \u00d8, Kvammen B\u00d8, Swartling C. Botulinum toxin type B for hidradenitis suppurativa: a randomised, double-blind, placebo-controlled pilot study. Am J Clin Dermatol. 2020;21(5):741\u20138.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"1712_CR87","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/phpp.12812","volume":"39","author":"S Reshetylo","year":"2023","unstructured":"Reshetylo S, Narla S, Bakker C, Freeman T, Farah RS, Hamzavi IH, et al. Systematic review of photodynamic therapy for the treatment of hidradenitis suppurativa. Photodermatol Photoimmunol Photomed. 2023;39(1):39\u201350.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1 Suppl","key":"1712_CR88","first-page":"S32","volume":"3","author":"M Gold","year":"2004","unstructured":"Gold M, Bridges TM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol. 2004;3(1 Suppl):S32-35.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"1712_CR89","first-page":"556","volume":"5","author":"J Rivard","year":"2006","unstructured":"Rivard J, Ozog D. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J Drugs Dermatol. 2006;5(6):556\u201361.","journal-title":"J Drugs Dermatol"},{"key":"1712_CR90","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.pdpdt.2018.04.014","volume":"22","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Yang Y, Zou X. Photodynamic therapy for hidradenitis suppurativa\/acne inversa: case report. Photodiagnosis Photodyn Ther. 2018;22:251\u20132.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1712_CR91","unstructured":"Treatment of recalcitrant hidradenitis suppurativa with photodynamic therapy: report of five cases - PubMed [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19508581\/"},{"key":"1712_CR92","doi-asserted-by":"crossref","unstructured":"Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa | British Journal of Dermatology | Oxford Academic [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/academic.oup.com\/bjd\/article-abstract\/152\/4\/803\/6636304?redirectedFrom=fulltext","DOI":"10.1111\/j.1365-2133.2005.06475.x"},{"key":"1712_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2021.102339","volume":"34","author":"J Garcias-Ladaria","year":"2021","unstructured":"Garcias-Ladaria J, Corral-Maga\u00f1a O, Del Pozo LJ, Mart\u00edn-Santiago A. Intralesional photodynamic therapy in hidradenitis suppurativa: getting closer to the target. Photodiagnosis Photodyn Ther. 2021;34:102339.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"1712_CR94","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/ced.12459","volume":"40","author":"MA Fadel","year":"2015","unstructured":"Fadel MA, Tawfik AA. New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study. Clin Exp Dermatol. 2015;40(2):116\u201322.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1712_CR95","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/c2pp25124h","volume":"12","author":"PG Calzavara-Pinton","year":"2013","unstructured":"Calzavara-Pinton PG, Rossi MT, Aronson E, Sala R, Italian Group For Photodynamic Therapy. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications. Photochem Photobiol Sci. 2013;12(1):148\u201357.","journal-title":"Photochem Photobiol Sci"},{"issue":"8","key":"1712_CR96","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1039\/c6pp00082g","volume":"15","author":"E Agut-Busquet","year":"2016","unstructured":"Agut-Busquet E, Roman\u00ed J, Gilaberte Y, Garc\u00eda-Malinis A, Ribera-Pibernat M, Luelmo J. Photodynamic therapy with intralesional methylene blue and a 635 nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective follow-up study in 7 patients and a review of the literature. Photochem Photobiol Sci. 2016;15(8):1020\u20138.","journal-title":"Photochem Photobiol Sci"},{"issue":"1","key":"1712_CR97","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/phpp.12709","volume":"38","author":"M Gamissans","year":"2022","unstructured":"Gamissans M, Riera-Mart\u00ed N, Roman\u00ed J, Gilaberte Y. Ultrasound-guided photodynamic therapy with intralesional methylene blue and a 635 nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective study of 41 patients. Photodermatol Photoimmunol Photomed. 2022;38(1):12\u20138.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"1712_CR98","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bjd\/ljae495","volume":"192","author":"SL Schell","year":"2025","unstructured":"Schell SL, Sennett ML, Feehan RP, Wallace TE, Meiszberg EC, Longenecker AL, et al. Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativa. Br J Dermatol. 2025;192(5):845\u201356. https:\/\/doi.org\/10.1093\/bjd\/ljae495.","journal-title":"Br J Dermatol"},{"key":"1712_CR99","unstructured":"Incyte Corporation. A Phase 2, Double-Blind, Randomized, Vehicle-Controlled, Efficacy, and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa [Internet]. clinicaltrials.gov; 2024 Oct [cited 2025 Jan 29]. Report No.: NCT05635838. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05635838"},{"key":"1712_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1145152","volume":"10","author":"M Daoud","year":"2023","unstructured":"Daoud M, Suppa M, Benhadou F, Daxhelet M, Njimi H, White J, et al. Overview and comparison of the clinical scores in hidradenitis suppurativa: a real-life clinical data. Front Med. 2023;10:1145152. https:\/\/doi.org\/10.3389\/fmed.2023.1145152.","journal-title":"Front Med"},{"issue":"2","key":"1712_CR101","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/bjd.18692","volume":"183","author":"JS Kirby","year":"2020","unstructured":"Kirby JS, Thorlacius L, Villumsen B, Ingram JR, Garg A, Christensen KB, et al. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials. Br J Dermatol. 2020;183(2):340\u20138. https:\/\/doi.org\/10.1111\/bjd.18692. (Epub 2019 Dec 26. PMID: 31705538; PMCID: PMC7205560.).","journal-title":"Br J Dermatol"},{"issue":"5","key":"1712_CR102","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40257-017-0280-2","volume":"18","author":"ARJV Vossen","year":"2017","unstructured":"Vossen ARJV, Schoenmakers A, van Straalen KR, Prens EP, van der Zee HH. Assessing pruritus in hidradenitis suppurativa: a cross-sectional study. Am J Clin Dermatol. 2017;18(5):687\u201395. https:\/\/doi.org\/10.1007\/s40257-017-0280-2. (PMID: 28429245; PMCID: PMC5602064.).","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"1712_CR103","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/bjd.21821","volume":"187","author":"SB Hasan","year":"2022","unstructured":"Hasan SB, Gendra R, James J, Morris D, Orenstein LAV, Ingram JR. Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: a scoping review to inform pain measurement in hidradenitis suppurativa. Br J Dermatol. 2022;187(6):846\u201354. https:\/\/doi.org\/10.1111\/bjd.21821. (Epub 2022 Sep 4. PMID: 35962565; PMCID: PMC10087046).","journal-title":"Br J Dermatol"},{"issue":"1","key":"1712_CR104","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3724","volume":"101","author":"PK Krajewski","year":"2021","unstructured":"Krajewski PK, Matusiak \u0141, von Stebut E, Schultheis M, Kirschner U, Nikolakis G, et al. Pain in hidradenitis suppurativa: a cross-sectional study of 1,795 patients. Acta Derm Venereol. 2021;101(1):adv00364. https:\/\/doi.org\/10.2340\/00015555-3724. (PMID: 33320274; PMCID: PMC9309859).","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"1712_CR105","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40257-021-00667-8","volume":"23","author":"S Ghanian","year":"2022","unstructured":"Ghanian S, Yamanaka-Takaichi M, Naik HB, Alavi A. Medical management of hidradenitis suppurativa with non-biologic therapy: what\u2019s new? Am J Clin Dermatol. 2022;23(2):167\u201376.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"1712_CR106","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1600-0781.2010.00499.x","volume":"26","author":"A Guglielmetti","year":"2010","unstructured":"Guglielmetti A, Bedoya J, Acuna M, Leiva V, Gonzalez S. Successful aminolevulinic acid photodynamic therapy for recalcitrant severe hidradenitis suppurativa. Photodermatol Photoimmunol Photomed. 2010;26(2):110\u20131.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1712_CR107","doi-asserted-by":"publisher","unstructured":"Solimani F, Meier K, Ghoreschi K. Emerging Topical and Systemic JAK Inhibitors in Dermatology. Front Immunol [Internet]. 2019 Dec 3 [cited 2024 Jun 12];10. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2019.02847\/full","DOI":"10.3389\/fimmu.2019.02847\/full"},{"issue":"5","key":"1712_CR108","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/bjd.20969","volume":"186","author":"A Alavi","year":"2022","unstructured":"Alavi A, Hamzavi I, Brown K, Santos LL, Zhu Z, Liu H, et al. Janus kinase 1 inhibitor INCB054707 for patients with moderate\u2010to\u2010severe hidradenitis suppurativa: results from two phase II studies. Br J Dermatol. 2022;186(5):803\u201313.","journal-title":"Br J Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01712-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01712-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01712-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:10:37Z","timestamp":1775106637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01712-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":108,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1712"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01712-2","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Elisa Molinelli has nothing to disclose. Davide Febi has nothing to disclose. Edoardo De Simoni has nothing to disclose. Maria Luisa Dragonetti has nothing to disclose. Irene Richiardi has nothing to disclose. Matteo Candelora has nothing to disclose. Daisy Gambini has nothing to disclose. Sara Belleggia has nothing to disclose. Guendalina Lucarini has nothing to disclose. Oriana Simonetti has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}